<p>Greater cell survival was found with the “high dose” transplants compared to “low dose” transplants, with a greater proportion of cells localizing to gray matter than white matter (<b>A</b>). Transplant-derived cells migrated from injection sites up to distances of 6 mm (<b>B</b>). All SOD1<sup>G93A</sup> animals had significantly reduced phrenic CMAP amplitudes at 130 days of age, however, there was no significant difference between hGRP and hF groups (<b>C</b>). There was no difference in cervical motor neuron survival between mice receiving hGRP and hF transplants at disease endstage (<b>D</b>).</p
<p>Lumbar transverse spinal cord sections from untreated, non-transgenic (Non-Tg; A) and untreated S...
Motor neuron loss is characteristic of many neurodegenerative disorders and results in rapid loss of...
Motor neuron loss is characteristic of many neurodegenerative disorders and results in rapid loss of...
<p>All SOD1<sup>G93A</sup> animals had significantly reduced phrenic CMAP amplitudes at 120 days of ...
<p>Unlike the lack of hGRP survival observed in SOD1<sup>G93A</sup> mice with CSA-based immune suppr...
<p>Compared to control “high dose” transplantation of hFs, “high dose” hGRP transplants in combinati...
<p>Approximately 10% of transplant-derived HuNA<sup>+</sup> cells continued to divide at disease end...
<p>HuNA<sup>+</sup> hGRP transplant-derived cells did not differentiate into βIII-Tubulin<sup>+</sup...
<p>Human GRP transplant-derived cells (from 4 injection sites: bilaterally at C4 and C5) dispersed t...
<p>Transplanted HuNA<sup>+</sup> hGRPs differentiated into GFAP<sup>+</sup> astrocytes by disease en...
<p>Compared to control transplantation of hFs, “low dose” hGRP transplantation in combination with C...
<p>Immunohistochemical analysis human GRP transplant-derived cells does not reveal expression of the...
<p>(A) Photomicrographs show the difference in striatal volumes in unilateral lesion mice. There was...
Cellular abnormalities are not limited to motor neurons in amyotrophic lateral sclerosis (ALS). Ther...
<p>At disease endstage, HuNA<sup>+</sup> cells co-labeled with the oligodendrocyte lineage marker, O...
<p>Lumbar transverse spinal cord sections from untreated, non-transgenic (Non-Tg; A) and untreated S...
Motor neuron loss is characteristic of many neurodegenerative disorders and results in rapid loss of...
Motor neuron loss is characteristic of many neurodegenerative disorders and results in rapid loss of...
<p>All SOD1<sup>G93A</sup> animals had significantly reduced phrenic CMAP amplitudes at 120 days of ...
<p>Unlike the lack of hGRP survival observed in SOD1<sup>G93A</sup> mice with CSA-based immune suppr...
<p>Compared to control “high dose” transplantation of hFs, “high dose” hGRP transplants in combinati...
<p>Approximately 10% of transplant-derived HuNA<sup>+</sup> cells continued to divide at disease end...
<p>HuNA<sup>+</sup> hGRP transplant-derived cells did not differentiate into βIII-Tubulin<sup>+</sup...
<p>Human GRP transplant-derived cells (from 4 injection sites: bilaterally at C4 and C5) dispersed t...
<p>Transplanted HuNA<sup>+</sup> hGRPs differentiated into GFAP<sup>+</sup> astrocytes by disease en...
<p>Compared to control transplantation of hFs, “low dose” hGRP transplantation in combination with C...
<p>Immunohistochemical analysis human GRP transplant-derived cells does not reveal expression of the...
<p>(A) Photomicrographs show the difference in striatal volumes in unilateral lesion mice. There was...
Cellular abnormalities are not limited to motor neurons in amyotrophic lateral sclerosis (ALS). Ther...
<p>At disease endstage, HuNA<sup>+</sup> cells co-labeled with the oligodendrocyte lineage marker, O...
<p>Lumbar transverse spinal cord sections from untreated, non-transgenic (Non-Tg; A) and untreated S...
Motor neuron loss is characteristic of many neurodegenerative disorders and results in rapid loss of...
Motor neuron loss is characteristic of many neurodegenerative disorders and results in rapid loss of...